These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22014766)

  • 1. Fulminant type 1 diabetes in Australia in the absence of humoral and cellular immune responses to pancreatic islet autoantigens.
    Lee I; Harrison LC; Colman PG
    Diabetes Res Clin Pract; 2012 Jan; 95(1):e4-6. PubMed ID: 22014766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient.
    Zanone MM; Favaro E; Quadri R; Miceli I; Giaretta F; Romagnoli R; David E; Perin PC; Salizzoni M; Camussi G
    Transpl Int; 2010 Mar; 23(3):333-7. PubMed ID: 19906032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
    Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
    Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus.
    Scherbaum WA; Seissler J
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():88-94. PubMed ID: 8839261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant type 1 diabetes mellitus-like presentation in a Hispanic woman in the United States.
    McCauley RA; Wang X
    Diabetes Metab; 2011 Sep; 37(4):356-8. PubMed ID: 21684789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
    J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targeting of islet autoantigens.
    Stadinski B; Kappler J; Eisenbarth GS
    Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes.
    Kawasaki E; Kuriya G; Satoh T; Fujishima K; Moriuchi A; Fukushima K; Ozaki M; Abiru N; Yamasaki H; Eguchi K
    Ann N Y Acad Sci; 2008 Dec; 1150():248-51. PubMed ID: 19120305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and immunological characteristics in rapid-onset type 1 diabetes with hyperamylasemia].
    Zhang C; Zhou ZG; Zhang DM; Yang XL; Zhou M; Lin J; Huang G; Wang JP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):967-71. PubMed ID: 16061004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is antigen specificity of autoreactive T cells the key to islet entry?
    Penaranda C; Bluestone JA
    Immunity; 2009 Oct; 31(4):534-6. PubMed ID: 19833083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell mediated immunity to islet cells: lessons from animal studies.
    Kolb H; Kiesel U; Flohr K; Greulich B; Freytag G; Kolb-Bachofen V
    Behring Inst Mitt; 1984 Jul; (75):33-8. PubMed ID: 6385952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant type 1 diabetes in Caucasians: A report of three cases.
    Moreau C; Drui D; Arnault-Ouary G; Charbonnel B; Chaillous L; Cariou B
    Diabetes Metab; 2008 Nov; 34(5):529-32. PubMed ID: 18829363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chinese patient presenting with clinical signs of fulminant type 1 diabetes mellitus.
    Katsumata K; Katsumata K
    Intern Med; 2005 Sep; 44(9):967-9. PubMed ID: 16258213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of insulin-dependent diabetes mellitus.
    Atkinson MA; Maclaren NK
    N Engl J Med; 1994 Nov; 331(21):1428-36. PubMed ID: 7969282
    [No Abstract]   [Full Text] [Related]  

  • 20. Islet autoimmunity and genetic mutations in Chinese subjects initially thought to have Type 1B diabetes.
    Zhang D; Zhou Z; Li L; Weng J; Huang G; Jing P; Zhang C; Peng J; Xiu L
    Diabet Med; 2006 Jan; 23(1):67-71. PubMed ID: 16409568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.